The Food and Drug Administration has granted approval for the first mRNA-based flu vaccine, according to an announcement by Moderna on Wednesday. This new vaccine is designed for adults aged 50 and over who seek immunization against the flu.
Moderna plans to make the newly approved vaccine available at select retailers in the coming weeks. This development arises amid controversy and skepticism, especially from figures like RFK Jr. regarding mRNA technology.
An image from 2024 captures a researcher at Moderna’s headquarters in Cambridge, Massachusetts, illustrating the path of continued research and development that led to this recent approval.
Leave a Reply